Cyclophosphamide-Loaded Microparticles for Cancer Therapy
Author Information
Author(s): Lipaikin Sergei, Dorokhin Aleksei, Ryltseva Galina, Oberenko Andrey, Kiselev Evgeniy, Shabanov Alexander, Volova Tatiana, Shishatskaya Ekaterina
Primary Institution: Siberian Federal University
Hypothesis
Can microencapsulation of cyclophosphamide into biodegradable polymeric matrices reduce its cytotoxicity and improve drug delivery?
Conclusion
The study found that microencapsulation of cyclophosphamide into PHBV microparticles reduced its cytotoxicity and provided a sustained release over 18 days.
Supporting Evidence
- The microparticles had a regular spherical shape and uniform size distribution.
- Encapsulation of cyclophosphamide decreased its cytotoxicity by 28% compared to the pure drug.
- The cumulative in vitro drug release showed a gradual release of cyclophosphamide over 18 days.
- The zeta potential of the microparticles indicated good stability.
- Encapsulation efficiency was measured at 23.3% and drug loading at 4.1%.
Takeaway
Researchers made tiny balls that hold a cancer medicine called cyclophosphamide, which helps it work better and hurt healthy cells less.
Methodology
The study involved preparing and characterizing cyclophosphamide-loaded PHBV microparticles using spray drying and assessing their properties through various tests.
Limitations
The encapsulation efficiency and drug loading were relatively low, which may limit the effectiveness of the delivery system.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website